| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |